Arkolith/Insider Trading/HQL/Form 4

Weinstein Boaz

10% Ownerabrdn Life Sciences Investors (HQL) · full profile →Form 4 · filed Jun 5, 2024
Net Buying
Open-Market Buys
$809K
Open-Market Sells
$0
Net Open-Market Flow
$809K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2024Buy(P)26K$13.76$359K3.4M
Jun 4, 2024Buy(P)33K$13.50$450K3.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001510281-24-000319) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML